SGLT2 inhibitors are indicated for three conditions: T2DM, chronic kidney disease, and chronic heart failure
Commissioned by the World Health Organization, the reviews will contribute to upcoming WHO guidelines on the use of GLP-1 receptor agonists for treating obesity
Coordination with Other Medications If you take other medications along with Semaglutide, a healthcare professional can help manage potential interactions
Since semaglutide users can lose an average of 15% of their body weight, some people may experience this type of hair shedding with rapid weight loss
Even foods that are high in natural sugars, such as dried fruits, may contribute to side effects if eaten in large amounts
Gastric protection with a proton pump inhibitor should be considered for patients requiring regular naproxen use, particularly those aged 65 or over or with a history of peptic ulcers